Nature and nurture: The future of predictor variables

Current Opinion in Critical Care

Volumn 6, Issue 3, 2000, Pages 166-170

  Mitchell, Imogen ^a  

^a CANBERRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CRITICAL ILLNESS; DISEASE SEVERITY; GENETIC SUSCEPTIBILITY; INTENSIVE CARE UNIT; OUTCOMES RESEARCH; REVIEW; SCORING SYSTEM; TREATMENT PLANNING;

EID: 0033928454     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-200006000-00004     Document Type: Review

References (43)

1. 1 Knaus WA, Draper E, Wagner D: Introduction in APACHE III study design: analytic plan for evaluation of severity and outcome. Crit Care Med 1989, 17:S176-S180.
2. 2 Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: A severity of disease classification system. Crit Care Med 1985, 13:818-829.
3. 3 Knaus WA, Zimmerman JE, Wagner DP, Draper EA: APACHE acute physiology and chronic health evaluation: a physiology-based classification system. Crit Care Med 1981, 9:591-597.
4. 4 Knaus WA, Wagner DP, Draper EA, Zimmerman JF, Bergner M, Bastos PG, et al.: The APACHE III prognostic system:rRisk prediction of hospital mortality for the critically ill hospitalized adults. Chest 1991, 100:1619-1636.
5. 5 Le Gall JR, Lemeshow S, Saulnier F: A new simplified acute physiology score (SAPS II). Based on a European/North American multicenter study. JAMA 1993, 270:2957-2963.
6. 6 Lemeshow S, Teres D, Klar J, Spitz Avrunin J, Gehlbach SH, Rapoport J: Mortality probability models (MPM II). Based on an international cohort of intensive care patients. JAMA 1993, 270:2478-2486.
7. 7 Zimmerman JE, Shortell SM, Rousseau DM, Duffy J, Gillies RR, Knaus WA, et al.: Improving intensive care: Observations based on organizational case studies in nine intensive care units: a prospective, multicenter study. Crit Care Med 1993, 21:1443-1451.
8. 8 Boyd O, Grounds RM: Physiological scoring systems and audit. Lancet 1993, 341:1573-1574.
9. 9 Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ: Increased morality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999, 341:785-92.
10. 10 Jennett B, Teasdale G, Braakman R, Minderhoud J, Knill-Jones R: Predicting outcome in individual patients after severe head injury. Lancet 1976, 1:1031-1034.
11. 11 Cullen DJ, Civetta JM, Briggs BA, Ferrara LC: Therapeutic intervention scoring system: a method for quantitative comparison of patient care. Crit Care Med 1974, 2:57-60.
12. 12 Cullen DJ, Keene R, Waternaux C, Kunsman JM, Caldera DL, Peterson H: Results, charges, benefits of intensive care for critically ill patients: update 1983. Crit Care Med 1984, 12:102-106.
13. 13 Yeung H-C, Lu M-W, Martinez EG, Puri VK: Critical care scoring system: new concept based on hemodynamic data. Crit Care Med 1989, 18:1347-1352.
14. 14 Shoemaker WC, Chang P, Czer L, Bland R, Shabot MM, State D: Cardiorespiratory monitoring in post operative patients: prediction of outcome and severity of illness. Crit Care Med 1979, 7:237-242.
15. 15 Afifi AA, Sacks ST, Liu VY, Weil MH, Shubin H: Accumulative prognostic index for patients with barbiturate glutethemide and meprobate intoxication. N Engl J Med 1971, 285:1497-1502.
16. 16 Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operator characteristic curve. Radiology 1982, 143:29-36.
17. 17 Lemeshow H, Hosmer DW: A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982, 115:92-106.
18. 18 Siegel JH, Goldwyn RM, Friedman HP: Patterns and process in the evaluation of human septic shock. Surgery 1971, 70:232-245.
19. 19 Siegel JH, Cerra FB, Moody EA, Shetye M, Coleman B, Garr L, et al.: The effect on survival of critically ill patients of an ICU teaching service organized about a computer-based physiologic CARE system. J Trauma 1980, 20:558-579.
20. 20 Bastos PG, Sun X, Wagner DP, Wu AW, Knaus WA: Glasgow Coma Scale score in the evaluation of outcome in the intensive care unit: findings from the Acute Physiology and Chronic Health Evaluation III study. Crit Care Med 1993, 21:1459-1465.
21. 21 Knaus WA, Draper EA, Wagner DP, Zimmerman JE: An evaluation of outcome from intensive care in major medical centres. Ann Intern Med 1986, 104:410-418.
22. 22 Bastos PG, Knaus WA, Zimmerman JE, Magalhaes A, Sun X, Wagner DP: The importance of technology for achieving superior outcomes from intensive care. Intensive Care Med 1996, 22:664-669.
23. 23 Tunnell RD, Millar BW, Smith GB: The effect of lead time bias on severity of illness scoring, mortality prediction and standardised mortality ration in intensive care: a pilot study. Anaesthesia 1999, 53:1045-1053.
24. 24 Goldhill DR, Sumner A: Outcome of intensive care patients in a group of British intensive care units. Crit Care Med 1998, 26:1337-1345.
25. 25 Castella X, Gilabert J, Torner F, Torres C: Mortality prediction models in intensive care: acute physiology and chronic health evaluation II and mortality prediction model compared. Crit Care Med 1991, 19:191-197.
26. 26 Wheeler AP, Bernard GR: Treating patients with severe sepsis. N Engl J Med 1999, 340:207-214. A good overview of current thoughts of managing severe sepsis.
27. 27 Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, et al.: Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987, 330:662-664.
28. 28 Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993, 119:771-778.
29. 29 Remick D, Manohar P, Bolgos G, Rodriguez J, Moldawer L, Wollenberg G: Blockade of tumour necrosis factor reduces lipopolysaccharide lethality, but not the lethality of caecal ligation and puncture. Shock 1995, 4:89-95.
30. 30 Echtenacher B, Falk W, Mannel DN, Krammer PH: Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 1990, 145:3762-3766.
31. 31 Presterl E, Staudinger T, Pettermann M, Lassnigg A, Burgmann H, Winkler S, et al.: Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. Am J Respir Crit Care Med 1997, 156:825-832.
32. 32 Talmor M, Hydo L, Barie PS: Relationship of systemic inflammatory response syndrome to organ dysfunction, length of stay, and mortality in critical surgical illness. Arch Surg 1999, 134:81-87.
33. 33 Friedland JS, Porter JC, Dayanani S, Bland JM, Screaton NJ, Vesley MJ, et al.: Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation III scores and survival in patients in an intensive care unit. Crit Care Med 1996, 24:1775-81173.
34. 34 Brown PO, Botstein D: Exploring the new world of the genome with DNA microarrays. Nat Genet 1999, 21 (suppl 1):33-37.
35. 35 Westendorp RGJ, Langermans JAM, Huizinga TWJ, Elouali AH, Verweij CL, Boosma DI, Vandenbrouke JP: Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997, 349:170-173.
36. 36 Stuber F, Peterson M, Bokelmann, Schade U: A genomic polymorphism within the tumour necrosis factor locus influences plasma tumour necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit Care Med 1996, 24:381-384.
37. 37 Mira JP, Cariou A, Grall F, et al.: Association of TNF2, a TNF-a promoter polymorphism, with septic shock susceptibility and mortality. A multicenter study. JAMA 1999, 282:561-568. A multicenter study observing 89 patients and 87 controls and differences in the TNF2 allele in those with and without sepsis and those that died with sepsis.
38. 38 Kumar A, Short J, Parrillo JE: Genetic factors in septic shock. JAMA 1999, 282:579-581.
39. 39 Majetschak M, Flohe S, Obertacke U, Schroder J, Staubach K, Nast-Kolb D, et al.: Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg 1999, 230:207-214.
40. 40 Fang XM, Schroder S, Hoeft A, Stuber F: Comparison of two polymorphisms of the interleukin-1 genefamily: interleukin-1 receptor antagonist polymorphism contributes to severe sepsis. Crit Care Med 1999, 27:1330-1334.
41. 41 Dinerallo CA: Is there an interleukin-1 genetic predisposition to developing severe sepsis? Crit Care Med 1999, 27:1397-1398.
42. 42 Bogardus ST, Concato J, Feinstein AR: Clinical epidemiological quality in molecular gentics research: the need for methodological standards. JAMA 1999, 281:1919-1926. A good overview of all the difficulties that surround genetic epidemiologic studies.
43. 43 Eachempati SR, Hydo L, Barie PS: Gender-based differences in outcome in patients with sepsis. Arch Surg 1999, 134:1342-1347.